Wagner Paul A.
Insider CIK 1612842 · FBRX See Remarks, Director, 10% owner · PFNX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 16,866 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 5,400 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 11,999 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 44,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 920,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 270,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 500,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,500 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 180,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 3,511 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | U Tender | 2026-08-27 | 2026-08-27 | 85,482 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 3,511 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 180,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,500 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 500,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 270,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 920,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 44,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 11,999 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 5,400 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 16,866 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | U Tender | 2026-08-27 | 2026-08-27 | 85,482 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-06 | 1,250 | — | $0 | 2,500 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2026-07-01 | 2026-07-06 | 98 | $21.32 | $2.1K | 85,482 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2026-07-01 | 2026-07-06 | 1,250 | — | $0 | 85,580 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2026-06-16 | 2026-06-17 | 500,000 | — | $0 | 500,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,250 | — | $0 | 3,750 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2026-04-01 | 2026-04-03 | 1,250 | — | $0 | 84,428 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2026-04-01 | 2026-04-03 | 98 | $24.86 | $2.4K | 84,330 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2026-01-12 | 2026-01-13 | 180,000 | — | $0 | 180,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2026-01-12 | 2026-01-13 | 270,000 | — | $0 | 270,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2026-01-01 | 2026-01-02 | 1,250 | — | $0 | 5,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2026-01-01 | 2026-01-02 | 164 | $27.27 | $4.5K | 83,178 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2026-01-01 | 2026-01-02 | 1,250 | — | $0 | 83,342 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2025-10-01 | 2025-10-02 | 1,250 | — | $0 | 6,250 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2025-10-01 | 2025-10-02 | 1,250 | — | $0 | 82,190 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2025-10-01 | 2025-10-02 | 98 | $14.52 | $1.4K | 82,092 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2025-07-01 | 2025-07-03 | 1,250 | — | $0 | 7,500 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2025-07-01 | 2025-07-03 | 1,250 | — | $0 | 81,038 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2025-07-01 | 2025-07-03 | 98 | $12.44 | $1.2K | 80,940 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-02 | 1,250 | — | $0 | 8,750 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2025-04-01 | 2025-04-02 | 1,250 | — | $0 | 79,806 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2025-04-01 | 2025-04-02 | 18 | $7.43 | $134 | 79,788 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2025-03-20 | 2025-03-21 | 920,000 | — | $0 | 920,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2025-01-01 | 2025-01-02 | 1,250 | — | $0 | 10,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2025-01-01 | 2025-01-02 | 1,250 | — | $0 | 78,720 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2025-01-01 | 2025-01-02 | 164 | $22.71 | $3.7K | 78,556 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-02 | 1,250 | — | $0 | 11,250 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2024-10-01 | 2024-10-02 | 98 | $5.16 | $506 | 77,470 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2024-10-01 | 2024-10-02 | 1,250 | — | $0 | 77,568 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2024-07-01 | 2024-07-03 | 31,250 | — | $0 | 312,500 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2024-07-01 | 2024-07-03 | 31,250 | — | $0 | 1,910,424 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2024-07-01 | 2024-07-03 | 2,453 | $0.55 | $1.3K | 1,907,971 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2024-04-01 | 2024-04-02 | 31,250 | — | $0 | 343,750 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2024-04-01 | 2024-04-02 | 2,453 | $0.71 | $1.7K | 1,879,174 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2024-04-01 | 2024-04-02 | 31,250 | — | $0 | 1,881,627 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 1,100,000 | — | $0 | 1,100,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2024-01-01 | 2024-01-03 | 31,250 | — | $0 | 375,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2024-01-01 | 2024-01-03 | 31,250 | — | $0 | 1,854,486 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2024-01-01 | 2024-01-03 | 4,109 | $0.82 | $3.4K | 1,850,377 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-12-18 | 2023-12-20 | 10,000 | $0.75 | $7.5K | 1,823,236 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-12-14 | 2023-12-15 | 10,000 | $0.72 | $7.2K | 1,813,236 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-12-13 | 2023-12-15 | 10,520 | $0.70 | $7.4K | 1,803,236 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-12-12 | 2023-12-12 | 4,776 | $0.65 | $3.1K | 1,792,716 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-12-11 | 2023-12-12 | 25,000 | $0.65 | $16.3K | 1,787,940 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-12-08 | 2023-12-08 | 15,000 | $0.62 | $9.3K | 1,762,940 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-12-07 | 2023-12-08 | 36,203 | $0.58 | $21.0K | 1,747,940 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-11-22 | 2023-11-22 | 400 | $0.43 | $172 | 1,711,737 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-11-20 | 2023-11-22 | 1,566 | $0.43 | $673 | 1,711,237 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-11-20 | 2023-11-22 | 100 | $0.43 | $43 | 1,711,337 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2023-11-20 | 2023-11-22 | 5,300 | $0.44 | $2.3K | 1,709,671 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2023-10-01 | 2023-10-03 | 31,250 | — | $0 | 406,250 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2023-10-01 | 2023-10-03 | 2,453 | $0.66 | $1.6K | 1,704,371 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2023-10-01 | 2023-10-03 | 31,250 | — | $0 | 1,706,824 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award | 2023-07-31 | 2023-08-02 | 247,524 | $1.01 | $250.0K | 1,675,574 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2023-07-01 | 2023-07-05 | 31,250 | — | $0 | 437,500 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2023-07-01 | 2023-07-05 | 2,453 | $1.04 | $2.6K | 1,428,050 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2023-07-01 | 2023-07-05 | 31,250 | — | $0 | 1,430,503 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2023-04-01 | 2023-04-04 | 31,250 | — | $0 | 468,750 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2023-04-01 | 2023-04-04 | 31,250 | — | $0 | 1,410,299 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2023-04-01 | 2023-04-04 | 11,046 | $1.01 | $11.2K | 1,399,253 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2023-03-23 | 2023-03-23 | 500,000 | — | $0 | 500,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2022-12-16 | 2022-12-19 | 44,024 | $1.07 | $47.1K | 1,379,049 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2022-12-15 | 2022-12-19 | 55,976 | $1.03 | $57.7K | 1,335,025 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2022-05-12 | 2022-05-16 | 40,000 | — | $0 | 135,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2022-01-17 | 2022-01-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | S Sale | 2021-09-07 | 2021-09-08 | 1,000,000 | $4.35 | $4.35M | 1,279,049 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2021-04-09 | 2021-04-13 | 175,000 | — | $0 | 175,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2020-06-25 | 2020-06-29 | 7,000 | $14.48 | $101.4K | 2,279,049 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2017-03-01 | 2017-03-02 | 85,000 | — | $0 | 85,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2017-03-01 | 2017-03-16 | 85,000 | — | $0 | 85,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2016-02-01 | 2016-02-01 | 83,940 | — | $0 | 83,940 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2015-04-01 | 2015-04-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2015-02-02 | 2015-02-03 | 30,750 | — | $0 | 30,750 | SEC↗ |